The Department of Agriculture has proposed a suite of measures aimed at reducing TB. WE analyse the implications for farmers ...

MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...

People with multiple sclerosis (MS) may receive less frequent infusions of rituximab without increasing their chances of relapse or disease progression, according to a real-world study from Norway.

Group, announced that the Phase 3 MUSETTE trial comparing a high dose of Ocrevus intravenous infusion to the currently approved Ocrevus IV 600 mg dose in people with relapsing multiple sclerosis did ...

Ocrevus is the first and only B-cell therapy approved for RMS and PPMS and after more than ten years of treatment, the majority of people with RMS remain free from disease progression,” said Levi ...

Arne Slot told Liverpool players their work rate in the Carabao Cup final was not acceptable during talks aimed at ...

San Francisco supervisors are pushing for more abstinence-based housing as state and federal lawmakers move away from housing ...

As Celebrity Big Brother returns to screens, we take a look back at the life of the show's first ever winner Jack Dee, who ...